Smarter Drug Management, Stronger Practices - Summary - MDSpire

Smarter Drug Management, Stronger Practices

  • By

  • Kurt Defenbaugh

  • May 18, 2026

Share

Objective:

To highlight the importance of effective drug management strategies for independent ophthalmology practices amidst a trend of consolidation in the industry, particularly focusing on the challenges posed by this shift.

Key Findings:
  • Less than half of physicians now work in private practice, down from 60% in 2012, indicating a significant shift in the industry.
  • Independent practices face challenges with traditional GPO and SD models that do not adapt to rising drug costs, impacting their financial viability.
  • Effective drug management can significantly enhance profitability for independent practices, making it a critical focus area.
Interpretation:

Independent ophthalmology practices must innovate their drug management strategies to thrive in a consolidating market, focusing on achieving flexibility, transparency, and technology integration through modern partnerships.

Limitations:
  • The article does not provide specific case studies or data to support the claims, which could strengthen the argument.
  • Potential biases in the perspective of the authors regarding GPO and SD partnerships may affect the objectivity of the analysis.
Conclusion:

Adopting smarter drug management practices is essential for independent ophthalmology practices to remain competitive and profitable in a changing healthcare landscape.

Original Source(s)

Related Content